Brazilian businessman Nelson Tanure may give up on Braskem deal

Brazilian businessman Nelson Tanure is poised to abandon his bid for a controlling stake in petrochemical firm Braskem as his exclusivity period nears its August 21 end, citing unresolved environmental liability from the Maceió ground subsidence incident as a non-negotiable condition. This potential withdrawal opens the door for private equity firm IG4 Capital, which is prepared to launch a rival bid by converting selling shareholder Novonor's bank debt into Braskem shares. The situation is further complicated by Unipar's recent $1 billion offer for Braskem's U.S. polypropylene plants, which lacks approval from key stakeholders.

Analysis

The potential acquisition of a controlling stake in Braskem by Brazilian businessman Nelson Tanure is on the verge of collapsing, creating significant uncertainty for the petrochemical firm's shares. The primary impediment is the unresolved environmental liability stemming from the Maceió ground subsidence incident, which Tanure has declared a "sine qua non" condition for his bid, insisting that no criminal or financial responsibility be transferred to new shareholders. With his 90-day exclusivity period ending on August 21, the market is pricing in a high probability of failure, reflected in the strongly negative per-ticker sentiment score of -0.7. The situation creates an opening for private equity firm IG4 Capital, which is reportedly prepared to launch a rival bid structured as a debt-for-equity swap with the seller, Novonor. This complex ownership battle is further complicated by a separate, unapproved $1 billion offer from Unipar for Braskem's U.S. polypropylene plants, indicating that any asset sale is secondary to resolving the core control and liability issues.

Key Decisions for Investors

• Investors should recognize the heightened risk of the current M&A premium dissipating, as Nelson Tanure's bid is likely to fail by the August 21 deadline due to the unresolved Maceió environmental liability.
• Monitor any announcements from rival bidder IG4 Capital post-exclusivity period, as their debt-for-equity proposal represents a different, but still uncertain, path forward for the company's ownership.
• The core investment thesis now hinges on the magnitude and resolution of the environmental claims, which have proven to be a poison pill for the current deal structure and will remain a major overhang on the stock.
• Treat the reported Unipar bid for U.S. assets with caution, as its viability is likely dependent on the primary M&A outcome and does not represent a near-term, standalone catalyst.